278 related articles for article (PubMed ID: 17624823)
1. New tuberculosis therapeutics: a growing pipeline.
Spigelman MK
J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Current development and future prospects in chemotherapy of tuberculosis.
Nuermberger EL; Spigelman MK; Yew WW
Respirology; 2010 Jul; 15(5):764-78. PubMed ID: 20546189
[TBL] [Abstract][Full Text] [Related]
4. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Nikonenko BV; Protopopova M; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2007 Apr; 51(4):1563-5. PubMed ID: 17242141
[TBL] [Abstract][Full Text] [Related]
5. Medicine. New TB drug promises shorter, simpler treatment.
Cohen J
Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
[No Abstract] [Full Text] [Related]
6. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
7. Microbiology. TB--a new target, a new drug.
Cole ST; Alzari PM
Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
[No Abstract] [Full Text] [Related]
8. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
9. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
10. Rising standards for tuberculosis drug development.
Balganesh TS; Alzari PM; Cole ST
Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
[TBL] [Abstract][Full Text] [Related]
11. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
[TBL] [Abstract][Full Text] [Related]
12. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis drug development: progress, challenges, and the road ahead.
Ginsberg AM
Tuberculosis (Edinb); 2010 May; 90(3):162-7. PubMed ID: 20382086
[TBL] [Abstract][Full Text] [Related]
14. Prospects for new tuberculosis treatment in Africa.
Mwinga A; Bernard Fourie P
Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
[TBL] [Abstract][Full Text] [Related]
15. New anti-tuberculosis drugs with novel mechanisms of action.
Rivers EC; Mancera RL
Curr Med Chem; 2008; 15(19):1956-67. PubMed ID: 18691051
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for active tuberculosis.
Ginsberg AM
Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.
Sacksteder KA; Protopopova M; Barry CE; Andries K; Nacy CA
Future Microbiol; 2012 Jul; 7(7):823-37. PubMed ID: 22827305
[TBL] [Abstract][Full Text] [Related]
18. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]